)
Visual
test
Xilio Therapeutics
Xilio Therapeutics (XLO) investor relations material
Xilio Therapeutics Proxy Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy Filing summary26 Jan, 2026
Executive summary
Special meeting scheduled for February 23, 2026, to be held virtually for all stockholders of record as of January 13, 2026.
Main agenda: vote on a reverse stock split amendment and potential adjournment to solicit more votes if needed.
Proxy materials distributed via full set delivery and available online.
Voting matters and shareholder proposals
Proposal 1: Approve an amendment to effect a reverse stock split at a ratio between 1-for-2 and 1-for-30, with the exact ratio and timing at the board's discretion.
Proposal 2: Approve adjournment of the meeting if more time is needed to solicit votes for Proposal 1.
Board unanimously recommends voting FOR both proposals.
Voting can be done online, by phone, by mail, or during the virtual meeting.
Board of directors and corporate governance
Board retains sole discretion on the reverse split ratio and timing within one year of stockholder approval.
Board may abandon the reverse split if deemed not in the best interests of the company or stockholders.
Factors guiding board's final split ratio
Key risks associated with the reverse split
Split's impact on capital structure
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- FODELIA
2025 saw 8.4% revenue growth, improved profitability, and strong 2026 guidance. - RUG
Record growth, higher margins, and a SEK 5 dividend proposal mark strong annual results. - JUBLINGREA
Volume growth offset pricing pressure; Q3'FY26 net profit at ₹47 crore, dividend declared. - ENITY
Record 2025 results: 10% loan growth, 19.2% RoTE, SEK 1.4 dividend, strong outlook. - FODELIA2025 net sales up 8.4%, strong Feelia growth, and higher sales and profitability expected in 2026.
- ELMD
Revenue up 15.1% to $16.9M, net income up 44.9%, and strong margins with active buybacks. - BETOLAR
Record order intake, strong sales growth, and advances in low-carbon technology and solutions. - NORION
Net profit up 14% to SEK 1,438m, driven by Consumer and Payments growth and share buybacks. - BILI
Strong results with higher earnings, robust cash flow, and strategic expansion in key markets. - NCC
Record profits in core segments, robust cash flow, and positive outlook despite major impairment.
Next Xilio Therapeutics earnings date
Q4 202511 Mar, 2026
Xilio Therapeutics
Next Xilio Therapeutics earnings date
Q4 202511 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Xilio Therapeutics, Inc. is a clinical-stage biotechnology firm focusing on discovering and developing tumor-activated immuno-oncology therapies. It focuses on creating treatments that are activated in the tumor environment, aiming to enhance the efficacy of immuno-oncology treatments while minimizing side effects. The company's portfolio includes a checkpoint inhibitor program with XTX101, an anti-CTLA-4 monoclonal antibody, alongside cytokine programs featuring XTX202 (a tumor-activated IL-2) and XTX301 (an engineered IL-12 molecule). The company is headquartered in Waltham, Massachusetts, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage